Find clinical trials for Non-Hodgkin Lymphoma in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Warszawa, Mazowieckie, POL:
This is a Phase I/II, multicenter, open-label, dose-escalation study designed to evaluate the efficacy, safety, tolerability and pharmacokinetics (PK...
Phase 1, Phase 2
Warszawa, Poland and 40 other locations
according to the Lugano Classification of response in malignant lymphoma (Cheson, 2014) and as assessed by independent central review in eac-...
Phase 2
Warszawa, Poland and 137 other locations
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolera...
Phase 1, Phase 2
Warszawa, Poland and 55 other locations
The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefi...
Phase 3
Warszawa, Mazowieckie, Poland and 55 other locations
This study evaluates the addition of nivolumab to gemcitabine, oxaliplatin plus rituximab in case of B-cell lymphoma...
Phase 2, Phase 3
Warsaw, Poland and 76 other locations
This study will provide continuing availability to tazemetostat for people that have previously completed participation in a tazemetostat study, eith...
Phase 1, Phase 2
Warszawa, Poland and 23 other locations
The primary purpose of the study is to assess safety, and to identify the recommended phase 2 dose (RP2D) of tolinapant in combination with oral deci...
Phase 1, Phase 2
Warsaw, Masovia, Poland and 45 other locations
The purpose of this study is to determine the side effects of treatment of the combination of nivolumab and daratumumab in participants with relapsed...
Phase 1, Phase 2
Warszawa, Poland and 42 other locations
This is a Phase 1 trial to evaluate the safety, pharmacokinetics and efficacy of TG-1701, a Bruton's Tyrosine Kinase (BTK) inhibitor in patients with...
Phase 1
Warszawa, Poland and 7 other locations
in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with previously untreated mantle cell lymphoma....
Phase 3
Warszawa, Poland and 227 other locations
Clinical trials
Research sites
Resources
Legal